Literature DB >> 3527085

Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis.

L E McGuigan, J K Prendergast, A F Geczy, J P Edmonds, H V Bashir.   

Abstract

We have previously shown that antisera raised in rabbits to certain enteric cross reactive strains of bacteria are capable of specifically lysing the peripheral blood lymphocytes of HLA-B27 positive patients with ankylosing spondylitis (B27+ AS+). We now report that bacteria with cross reactive antigenic determinants are found in the bowel flora of all of 52 B27+ AS+ patients but in only one of 50 HLA-B27 positive normal controls (B27+ AS-). These organisms are functionally similar to the cross reactive enteric bacteria originally reported. They are not confined to a particular genus or species and their cross reactive serological nature appears to be a property shared by all enteric organisms isolated from B27+ AS+ patients. Organisms with these properties have been shown to persist in the bowel flora of 14 B27+ AS+ patients followed up for more than one year.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527085      PMCID: PMC1001938          DOI: 10.1136/ard.45.7.566

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Clinical history as a screening test for ankylosing spondylitis.

Authors:  A Calin; J Porta; J F Fries; D J Schurman
Journal:  JAMA       Date:  1977-06-13       Impact factor: 56.272

2.  Discordance for ankylosing spondylitis in monozygotic twins.

Authors:  C J Eastmond; J C Woodrow
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

3.  HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.

Authors:  K Aho; P Ahvonen; A Lassus; K Sievers; A Tiilikainen
Journal:  Arthritis Rheum       Date:  1974 Sep-Oct

4.  Reiter's disease and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; J K Oates; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

5.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

6.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

7.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

8.  Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis.

Authors:  J K Prendergast; L E McGuigan; A F Geczy; T S Kwong; J P Edmonds
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

9.  A factor(s) in Klebsiella culture filtrates specifically modifies an HLA-B27 associated cell-surface component.

Authors:  A F Geczy; K Alexander; H V Bashir; J Edmonds
Journal:  Nature       Date:  1980-02-21       Impact factor: 49.962

10.  An objective clinical study of chest expansion.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1972-01       Impact factor: 19.103

View more
  5 in total

1.  Ig A antibodies to klebsiella in ankylosing spondylitis.

Authors:  O Ardiçoğlu; M B Atay; H Ataoğlu; N Etiz; H Ozenci
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

Review 2.  Progress in uveitis.

Authors:  D J Spalton
Journal:  Br J Ophthalmol       Date:  1988-02       Impact factor: 4.638

3.  Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment.

Authors:  H G Taylor; E J Beswick; P T Dawes
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

4.  Failure of the serological determination of HLA-B27 due to antigen masking in patients with ankylosing spondylitis.

Authors:  J Neumüller; M Fischer; R Eberl
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

Review 5.  Chronic sequelae of foodborne disease.

Authors:  J A Lindsay
Journal:  Emerg Infect Dis       Date:  1997 Oct-Dec       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.